Neoantigens expressed in ovarian cancer and their uses | Patent Publication Number 20210261609

US 20210261609 A1
Patent NumberUS 11945881 B2
Application Number17174505
Filled DateFeb 12, 2021
Priority Date-
Publication DateAug 26, 2021
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsManuel Alejandro Sepulveda
Pegah Safabakhsh
Vinod Krishna
David J. Pocalyko
Vipul Bhargava
Vipul BHARGAVA
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.